학술논문
Final analysis of potential drug–drug interactions between highly purified cannabidiol and anti‐seizure medications in an open‐label expanded access program.
Document Type
Article
Source
Epilepsia Open; Dec2023, Vol. 8 Issue 4, p1405-1412, 8p
Subject
Language
ISSN
24709239
Abstract
Copyright of Epilepsia Open is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)